Skip to main content
Top
Published in: Infection 6/2010

01-12-2010 | Case Report

Pitfalls of “hyper”-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature

Authors: A. Heinold, B. Hanebeck, V. Daniel, J. Heyder, T. H. Tran, B. Döhler, J. Greil, F.-M. Müller

Published in: Infection | Issue 6/2010

Login to get access

Abstract

Here, we report on a male infant with low serum IgG, IgA and IgM levels who suffered from Pneumocystis jirovecii and cytomegalovirus (CMV) pneumonia. The patient was tested to be HIV-negative. Absolute and relative numbers of lymphocyte subsets were normal, excluding the diagnosis of an X-linked agammaglobulinaemia (Bruton’s disease). Despite the decreased serum IgM level, an X-linked hyper-IgM syndrome (X-HIGM) was considered. X-HIGM is a rare immunodeficiency usually characterised by recurrent severe opportunistic infections, low serum IgG and IgA, but normal or increased serum IgM. The syndrome is caused by mutations of the CD40 ligand (CD40L) gene. In our patient, CD40L mutation analysis proved a novel mutation at codon 257 associated with non-detectable expression of CD40L on the surface of activated T cells. A literature search revealed that approximately 6.4% of X-HIGM patients had been found to have low serum IgM levels. Our statistical analysis of the IgM levels as reported by different studies arouses suspicion that many patients with low IgM levels may not have undergone diagnostic procedures for X-HIGM. In summary, in this report and critical review of the literature, we described a new mutation of CD40L and highlighted the pitfalls of the diagnosis of X-HIGM.
Literature
1.
2.
go back to reference Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54.CrossRefPubMed Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54.CrossRefPubMed
3.
go back to reference Ostenstad B, Giliani S, Mellbye OJ, Nilsen BR, Abrahamsen T. A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency. Clin Exp Immunol. 1997;107:230–4.CrossRefPubMed Ostenstad B, Giliani S, Mellbye OJ, Nilsen BR, Abrahamsen T. A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency. Clin Exp Immunol. 1997;107:230–4.CrossRefPubMed
4.
go back to reference Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259:990–3.CrossRefPubMed Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259:990–3.CrossRefPubMed
5.
go back to reference Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291–300.CrossRefPubMed Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291–300.CrossRefPubMed
6.
go back to reference DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:541–3.CrossRefPubMed DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:541–3.CrossRefPubMed
7.
go back to reference Korthäuer U, Graf D, Mages HW, Brière F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:539–41.CrossRefPubMed Korthäuer U, Graf D, Mages HW, Brière F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:539–41.CrossRefPubMed
8.
go back to reference Kroczek RA, Graf D, Brugnoni D, Giliani S, Korthüer U, Ugazio A, Senger G, Mages HW, Villa A, Notarangelo LD. Defective expression of CD40 ligand on T cells causes “X-linked immunodeficiency with hyper-IgM (HIGM1)”. Immunol Rev. 1994;138:39–59.CrossRefPubMed Kroczek RA, Graf D, Brugnoni D, Giliani S, Korthüer U, Ugazio A, Senger G, Mages HW, Villa A, Notarangelo LD. Defective expression of CD40 ligand on T cells causes “X-linked immunodeficiency with hyper-IgM (HIGM1)”. Immunol Rev. 1994;138:39–59.CrossRefPubMed
9.
go back to reference Durandy A. Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation. Biochem Soc Trans. 2002;30:815–8.CrossRefPubMed Durandy A. Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation. Biochem Soc Trans. 2002;30:815–8.CrossRefPubMed
10.
go back to reference Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol. 1992;22:2573–8.CrossRefPubMed Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol. 1992;22:2573–8.CrossRefPubMed
11.
12.
go back to reference Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, Gharagozlou M. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica. 2005;90:554–6.PubMed Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, Gharagozlou M. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica. 2005;90:554–6.PubMed
13.
go back to reference Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, Imanzadeh A, Mohammadi J, Hammarström L. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009;29:769–76.CrossRefPubMed Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, Imanzadeh A, Mohammadi J, Hammarström L. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009;29:769–76.CrossRefPubMed
14.
go back to reference Katz F, Hinshelwood S, Rutland P, Jones A, Kinnon C, Morgan G. Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Hum Mutat. 1996;8:223–8.CrossRefPubMed Katz F, Hinshelwood S, Rutland P, Jones A, Kinnon C, Morgan G. Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Hum Mutat. 1996;8:223–8.CrossRefPubMed
15.
go back to reference Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105:1881–90.CrossRefPubMed Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105:1881–90.CrossRefPubMed
16.
go back to reference Thusberg J, Vihinen M. The structural basis of hyper IgM deficiency—CD40L mutations. Protein Eng Des Sel. 2007;20:133–41.CrossRefPubMed Thusberg J, Vihinen M. The structural basis of hyper IgM deficiency—CD40L mutations. Protein Eng Des Sel. 2007;20:133–41.CrossRefPubMed
17.
go back to reference Callard RE, Smith SH, Herbert J, Morgan G, Padayachee M, Lederman S, Chess L, Kroczek RA, Fanslow WC, Armitage RJ. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers. J Immunol. 1994;153:3295–306.PubMed Callard RE, Smith SH, Herbert J, Morgan G, Padayachee M, Lederman S, Chess L, Kroczek RA, Fanslow WC, Armitage RJ. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers. J Immunol. 1994;153:3295–306.PubMed
18.
go back to reference Piirilä H, Väliaho J, Vihinen M. Immunodeficiency mutation databases (IDbases). Hum Mutat. 2006;27:1200–8.CrossRefPubMed Piirilä H, Väliaho J, Vihinen M. Immunodeficiency mutation databases (IDbases). Hum Mutat. 2006;27:1200–8.CrossRefPubMed
19.
go back to reference Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3:101–21.PubMed Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3:101–21.PubMed
20.
go back to reference Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–84.CrossRef Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–84.CrossRef
21.
go back to reference Gilmour KC, Walshe D, Heath S, Monaghan G, Loughlin S, Lester T, Norbury G, Cale CM. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. Mol Pathol. 2003;56:256–62.CrossRefPubMed Gilmour KC, Walshe D, Heath S, Monaghan G, Loughlin S, Lester T, Norbury G, Cale CM. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. Mol Pathol. 2003;56:256–62.CrossRefPubMed
22.
go back to reference Leone V, Tommasini A, Andolina M, Runti G, De Vonderweid U, Campello C, Notarangelo LD, Ventura A. Elective bone marrow transplantation in a child with X-linked hyper-IgM syndrome presenting with acute respiratory distress syndrome. Bone Marrow Transplant. 2002;30:49–52.CrossRefPubMed Leone V, Tommasini A, Andolina M, Runti G, De Vonderweid U, Campello C, Notarangelo LD, Ventura A. Elective bone marrow transplantation in a child with X-linked hyper-IgM syndrome presenting with acute respiratory distress syndrome. Bone Marrow Transplant. 2002;30:49–52.CrossRefPubMed
23.
go back to reference Pienaar S, Eley BS, Hughes J, Henderson HE. X-linked hyper IgM (HIGM1) in an African kindred: the first report from South Africa. BMC Pediatr. 2003;3:12.CrossRefPubMed Pienaar S, Eley BS, Hughes J, Henderson HE. X-linked hyper IgM (HIGM1) in an African kindred: the first report from South Africa. BMC Pediatr. 2003;3:12.CrossRefPubMed
24.
go back to reference Macchi P, Villa A, Strina D, Sacco MG, Morali F, Brugnoni D, Giliani S, Mantuano E, Fasth A, Andersson B, Zegers BJM, Cavagni G, Reznick I, Levy J, Zan-Bar I, Porat Y, Airo P, Piebani A, Vezzoni P, Notarangelo LD. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am J Hum Genet. 1995;56:898–906.PubMed Macchi P, Villa A, Strina D, Sacco MG, Morali F, Brugnoni D, Giliani S, Mantuano E, Fasth A, Andersson B, Zegers BJM, Cavagni G, Reznick I, Levy J, Zan-Bar I, Porat Y, Airo P, Piebani A, Vezzoni P, Notarangelo LD. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am J Hum Genet. 1995;56:898–906.PubMed
25.
go back to reference Nonoyama S, Shimadzu M, Toru H, Seyama K, Nunoi H, Neubauer M, Yata J, Och HD. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet. 1997;99:624–7. Nonoyama S, Shimadzu M, Toru H, Seyama K, Nunoi H, Neubauer M, Yata J, Och HD. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet. 1997;99:624–7.
26.
go back to reference Prasad ML, Velickovic M, Weston SA, Benson EM. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives. J Clin Pathol. 2005;58:90–2.CrossRefPubMed Prasad ML, Velickovic M, Weston SA, Benson EM. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives. J Clin Pathol. 2005;58:90–2.CrossRefPubMed
27.
go back to reference Andrews FJ, Katz F, Jones A, Smith S, Finn A. CD40 ligand deficiency presenting as unresponsive neutropenia. Arch Dis Child. 1996;74:458–9.CrossRefPubMed Andrews FJ, Katz F, Jones A, Smith S, Finn A. CD40 ligand deficiency presenting as unresponsive neutropenia. Arch Dis Child. 1996;74:458–9.CrossRefPubMed
28.
go back to reference Apoil PA, Kuhlein E, Robert A, Rubie H, Blancher A. HIGM syndrome caused by insertion of an AluYb8 element in exon 1 of the CD40LG gene. Immunogenetics. 2007;59:17–23.CrossRefPubMed Apoil PA, Kuhlein E, Robert A, Rubie H, Blancher A. HIGM syndrome caused by insertion of an AluYb8 element in exon 1 of the CD40LG gene. Immunogenetics. 2007;59:17–23.CrossRefPubMed
29.
go back to reference Aschermann Z, Gomori E, Kovacs GG, Pal E, Simon G, Komoly S, Marodi L, Illes Z. X-linked hyper-IgM syndrome associated with a rapid course of multifocal leukoencephalopathy. Arch Neurol. 2007;64:273–6.CrossRefPubMed Aschermann Z, Gomori E, Kovacs GG, Pal E, Simon G, Komoly S, Marodi L, Illes Z. X-linked hyper-IgM syndrome associated with a rapid course of multifocal leukoencephalopathy. Arch Neurol. 2007;64:273–6.CrossRefPubMed
30.
go back to reference Cunningham CK, Bonville CA, Ochs HD, Seyama K, John PA, Rotbart HA, Weiner LB. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr. 1999;134:584–8.CrossRefPubMed Cunningham CK, Bonville CA, Ochs HD, Seyama K, John PA, Rotbart HA, Weiner LB. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr. 1999;134:584–8.CrossRefPubMed
31.
go back to reference García-Pérez MA, Paz-Artal E, Corell A, Moreno A, López-Goyanes A, García-Martín F, Vázquez R, Pacho A, Romo E, Allende LM. Mutations of CD40 ligand in two patients with hyper-IgM syndrome. Immunobiology. 2003;207:285–94.CrossRefPubMed García-Pérez MA, Paz-Artal E, Corell A, Moreno A, López-Goyanes A, García-Martín F, Vázquez R, Pacho A, Romo E, Allende LM. Mutations of CD40 ligand in two patients with hyper-IgM syndrome. Immunobiology. 2003;207:285–94.CrossRefPubMed
32.
go back to reference Janić D, Radlović N, Dokmanović L, Krstovski N, Leković Z, Janković S, Ristić D. Hyper-IgM syndrome in a boy with recurrent pneumonia and hepatosplenomegaly. Srp Arh Celok Lek. 2009;137:81–5.CrossRefPubMed Janić D, Radlović N, Dokmanović L, Krstovski N, Leković Z, Janković S, Ristić D. Hyper-IgM syndrome in a boy with recurrent pneumonia and hepatosplenomegaly. Srp Arh Celok Lek. 2009;137:81–5.CrossRefPubMed
33.
go back to reference Jo EK, Kim HS, Lee MY, Iseki M, Lee JH, Song CH, Park JK, Hwang TJ, Kook H. X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformans infections: the first case with molecular diagnosis in Korea. J Korean Med Sci. 2002;17:116–20.PubMed Jo EK, Kim HS, Lee MY, Iseki M, Lee JH, Song CH, Park JK, Hwang TJ, Kook H. X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformans infections: the first case with molecular diagnosis in Korea. J Korean Med Sci. 2002;17:116–20.PubMed
34.
go back to reference Koike M, Oshimi K, Agematu K, Futani T. Type 1 hyper-IgM syndrome diagnosed in a 28-year-old patient with recurrent infections since childhood. Rinsho Ketsueki. 2006;47:1377–80.PubMed Koike M, Oshimi K, Agematu K, Futani T. Type 1 hyper-IgM syndrome diagnosed in a 28-year-old patient with recurrent infections since childhood. Rinsho Ketsueki. 2006;47:1377–80.PubMed
35.
go back to reference Lin SC, Shyur SD, Lee WI, Ma YC, Huang LH. X-linked hyper-immunoglobulin M syndrome: molecular genetic study and long-time follow-up of three generations of a Chinese family. Int Arch Allergy Immunol. 2006;140:1–8.CrossRefPubMed Lin SC, Shyur SD, Lee WI, Ma YC, Huang LH. X-linked hyper-immunoglobulin M syndrome: molecular genetic study and long-time follow-up of three generations of a Chinese family. Int Arch Allergy Immunol. 2006;140:1–8.CrossRefPubMed
36.
go back to reference Lin SC, Shyur SD, Ma YC, Huang LH, Lee WI. Hyper-IgM1 syndrome with interstitial pneumonia and diarrhea caused by coxsackievirus B4 in a 3-month-old infant. Ann Allergy Asthma Immunol. 2005;95:93–7.CrossRefPubMed Lin SC, Shyur SD, Ma YC, Huang LH, Lee WI. Hyper-IgM1 syndrome with interstitial pneumonia and diarrhea caused by coxsackievirus B4 in a 3-month-old infant. Ann Allergy Asthma Immunol. 2005;95:93–7.CrossRefPubMed
37.
go back to reference López-Granados E, Cambronero R, Ferreira A, Fontán G, García-Rodríguez MC. Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome. Clin Exp Immunol. 2003;133:123–31.CrossRefPubMed López-Granados E, Cambronero R, Ferreira A, Fontán G, García-Rodríguez MC. Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome. Clin Exp Immunol. 2003;133:123–31.CrossRefPubMed
38.
go back to reference Ma YC, Lee WI, Shyur SD, Lin SC, Huang LH, Wu JY. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan. Asian Pac J Allergy Immunol. 2005;23:53–9.PubMed Ma YC, Lee WI, Shyur SD, Lin SC, Huang LH, Wu JY. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan. Asian Pac J Allergy Immunol. 2005;23:53–9.PubMed
39.
go back to reference Rangel-Santos A, Wakim VL, Jacob CM, Pastorino AC, Cunha JM, Collanieri AC, Niemela JE, Grumach AS, Duarte AJ, Moraes-Vasconcelos D, Oliveira JB. Molecular characterization of patients with X-linked Hyper-IgM syndrome: description of two novel CD40L mutations. Scand J Immunol. 2009;69:169–73.CrossRefPubMed Rangel-Santos A, Wakim VL, Jacob CM, Pastorino AC, Cunha JM, Collanieri AC, Niemela JE, Grumach AS, Duarte AJ, Moraes-Vasconcelos D, Oliveira JB. Molecular characterization of patients with X-linked Hyper-IgM syndrome: description of two novel CD40L mutations. Scand J Immunol. 2009;69:169–73.CrossRefPubMed
40.
go back to reference Santadusit S, Visitsunthon N, Ochs HD, Vichyanond P. X-linked hyper IgM syndrome: a report of the first case in Thailand with a confirmed mutation of CD40 ligand gene. Asian Pac J Allergy Immunol. 2000;18:165–8.PubMed Santadusit S, Visitsunthon N, Ochs HD, Vichyanond P. X-linked hyper IgM syndrome: a report of the first case in Thailand with a confirmed mutation of CD40 ligand gene. Asian Pac J Allergy Immunol. 2000;18:165–8.PubMed
41.
go back to reference Zhu X, Chung I, O’Gorman MR, Scholl PR. Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome. Clin Immunol. 2001;99:334–9.CrossRefPubMed Zhu X, Chung I, O’Gorman MR, Scholl PR. Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome. Clin Immunol. 2001;99:334–9.CrossRefPubMed
Metadata
Title
Pitfalls of “hyper”-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature
Authors
A. Heinold
B. Hanebeck
V. Daniel
J. Heyder
T. H. Tran
B. Döhler
J. Greil
F.-M. Müller
Publication date
01-12-2010
Publisher
Urban and Vogel
Published in
Infection / Issue 6/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0061-9

Other articles of this Issue 6/2010

Infection 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine